| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.6 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.093 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |